Navigation Links
Introduction of Microbial Organisms: A Possible Treatment for Asthma

According to the researchers at the University of California, San Francisco (UCSF) it is possible to treat asthma in children using micro organisms. // Probiotics supplements in infants and children are a novel method for the primary prevention of asthma. Michael Cabana, MD, chief of the Department of General Pediatrics at UCSF Children's Hospital and principal investigator for the study said that till date there is no specific way by which one can prevent asthma. "It would be a great thing to be able to prevent asthma, Cabana said. We believe that using probiotics is a safe and effective way to do that.

Probiotics are defined as micro-organisms administered in adequate amounts to confer beneficial health effects. They typically are chosen from bacteria that normally inhabit the gastrointestinal system and are therefore known to be safe. Asthma is one of the most common chronic diseases of childhood and the most common cause of school absenteeism. Asthma is an inflammation of the bronchial tubes that causes airway obstruction, chest tightness, coughing and wheezing. Called the Trial of Infant Probiotic Supplementation to Prevent Asthma, or TIPS, the study is based on the hygiene hypothesis, which says that little or no exposure to bacteria and viruses during a critical period of infancy can lead to an imbalance in the immune system and result in diseases such as asthma, especially in high-risk groups, like children with parents who have asthma. The study seeks to determine whether stimulating the immune system by giving an active probiotic supplement, Lactobacillus GG, can prevent or delay the appearance of early signs of asthma, such as wheezing, frequent runny nose, and eczema.

Lactobacillus GG is a common bacterium found in yogurt and many other foods and often is given to treat diarrhea. The three-year study will include about 280 healthy full-term babies with either a mother or a father with asthma, because parents with asthma are more like ly to have children with asthma. During the first six months of life, half of the infants will receive a once-daily dose of active Lactobacillus GG and half will receive a placebo. The babies will be followed for three years, with six follow-up visits at UCSF Children's Hospital or an outpatient center starting at one month old. Researchers will analyze the data from the visits to see if the active supplements prevented or delayed the appearance of the early signs of asthma. Cabana said a similar study conducted in Finland found that administration of Lactobacillus to infants delayed or prevented the onset of eczema.

According to the American Lung Association, an estimated 4 million children under 18 years old have had an asthma attack in the past 12 months, and many others have hidden or undiagnosed asthma. Other study co-investigators include Joan Hilton, ScD; Cewin Chao, MS, RD, MBA; Homer Boushey, MD; Lawrence Fong, MD, PhD; and Aaron Brandon Caughey, MD, MPP, MPH, all of UCSF.

Source: Eurekalert
'"/>




Related medicine news :

1. Ramdoss Announces Introduction of RCH-II
2. Earlier Introduction of Solid Foods in Infants Could Prevent Wheat Allergy
3. IMA Oppose Introduction of Polio Injections
4. Anti-Microbial Coating For Use Over Biomedical Devices Developed
5. Misuse Of Anti-Microbial Drugs Have Given Rise To Multidrug-resistant TB Strains
6. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
7. Possible benefits of Hormone Replacement Therapy
8. Low Protein Levels A Possible Indicator For A Miscarriage
9. Cure For Persistent Oral Fungal Problem May Be Possible
10. Transfer Of Rabies Virus Possible From Organ Donor To Recipient
11. Possible location of lung cancer genes found
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2016)... Angeles, CA (PRWEB) , ... February 10, 2016 ... ... Programming (NLP) practitioner, is known locally for a series of therapeutic sessions to ... in-the-moment in their characters and in their lives. The series, known as “Mindfulness ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... unveiling its revolutionary new 2.0 version at the International Roofing Expo in Orlando, ... power of the world's most advanced weather technology in the hands of consumers, ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... master charity program created to assist the local community. Pledging to select a ... and nonprofit organizations in the area. Their goal is to bring community awareness ...
(Date:2/10/2016)... ... ... Ongoing news of the ravages of traumatic brain injury (TBI) among former ... takes a closer look at cases of TBI being managed by their members. The ... the aging population, and identifies the challenges associated with their care. , During the ...
(Date:2/10/2016)... ... February 10, 2016 , ... Armune BioScience signed a ... network of laboratory service centers across the country. Launched in April of 2015, Apifiny ... detection of prostate cancer. Apifiny order volume exceeded 3,000 tests in 2015. Primary care ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... -- Mast Therapeutics, Inc. (NYSE MKT: MSTX), ... cell disease and heart failure, today announced the pricing ... a price to the public of $0.275 per unit. ... common stock and one warrant to purchase one share ... of $0.42 per share. The warrants are exercisable six ...
(Date:2/10/2016)... Feb. 10, 2016  Silicon Biosystems Menarini Inc., ... that help uncover the biological complexities of disease ... a developer of innovative technologies for genomics research, ... aimed at enabling translational researchers to obtain high-quality ... hundred tumor and normal cells in an optimized ...
(Date:2/10/2016)... Feb. 9, 2016 CTI BioPharma Corp. ... an update regarding the clinical studies being conducted ... for pacritinib. Following the issuance of the Company,s ... clinical hold issued by the U.S. Food and ... Company received an oral communication from the FDA ...
Breaking Medicine Technology: